Telix Pharmaceuticals Limited (ASX:TLX)
Australia · Delayed Price · Currency is AUD 16.09
+0.51 (3.27%)
Aug 28, 2026, 10:24 AM AEST
Telix Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 251.91 | 141.87 | 440 | 84.3 | 79.07 | 16.02 |
Cash & Short-Term Investments | 251.91 | 141.87 | 440 | 84.3 | 79.07 | 16.02 |
Cash Growth | 21.60% | -67.76% | 421.98% | 6.61% | 393.44% | -73.35% |
Accounts Receivable | 163.56 | 129.2 | 86.93 | 44.04 | 26.75 | 0.53 |
Other Receivables | 6.83 | 9.17 | 12.73 | 5.24 | 4.46 | 14.63 |
Receivables | 170.39 | 138.37 | 99.65 | 49.28 | 31.21 | 15.16 |
Inventory | 39.03 | 37.08 | 23.62 | 12.74 | 5.76 | 2.51 |
Prepaid Expenses | - | 12.96 | 6.84 | - | 1.7 | 0.88 |
Other Current Assets | 26.69 | - | - | 12.38 | - | - |
Total Current Assets | 488.02 | 330.28 | 570.12 | 158.69 | 117.74 | 34.57 |
Property, Plant & Equipment | 129.63 | 115.61 | 33.65 | 20.86 | 12.8 | 4.6 |
Long-Term Investments | 40.41 | 3.68 | 3.77 | - | - | - |
Goodwill | 197.51 | 198.99 | 66.59 | - | 3.75 | 2.98 |
Other Intangible Assets | 387.1 | 393.84 | 191.27 | 75.05 | 36.34 | 37.54 |
Long-Term Deferred Tax Assets | 85.3 | 59.35 | 28.92 | 13.99 | 2.7 | - |
Other Long-Term Assets | 33.89 | 62.24 | 46.06 | 8.66 | 0.22 | 0.15 |
Total Assets | 1,362 | 1,164 | 940.38 | 277.26 | 173.56 | 79.85 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 168.97 | 71.66 | 42.23 | 54.33 | 11.42 | 8.64 |
Accrued Expenses | 20.29 | 52.63 | 47.94 | 9.53 | 25.23 | 8.48 |
Short-Term Debt | - | - | - | - | - | 0.01 |
Current Portion of Long-Term Debt | 11.51 | 13.11 | 11.76 | 0.66 | - | - |
Current Portion of Leases | 3.92 | 5.55 | 1.55 | 0.41 | 0.44 | 0.45 |
Current Income Taxes Payable | 33.85 | 30.74 | 30.09 | 13.11 | 4.98 | - |
Current Unearned Revenue | 0.91 | 0.96 | 7.54 | 7.92 | 3.63 | 4.51 |
Other Current Liabilities | 2.9 | 56.97 | 63.99 | 25.42 | 12.46 | 5.53 |
Total Current Liabilities | 242.34 | 231.62 | 205.09 | 111.37 | 58.15 | 27.62 |
Long-Term Debt | 504.88 | 391.91 | 341.81 | 5.95 | 2.25 | - |
Long-Term Leases | 59.56 | 56.53 | 5.04 | 5.25 | 4.41 | 1.39 |
Long-Term Unearned Revenue | - | 1.48 | 3.32 | 8.32 | 16.77 | 17.84 |
Pension & Post-Retirement Benefits | 0.61 | 0.44 | 0.31 | 0.21 | 0.15 | 0.1 |
Long-Term Deferred Tax Liabilities | 43.3 | 44.71 | 5.8 | - | - | - |
Other Long-Term Liabilities | 23.49 | 21.9 | 26.08 | 43.51 | 37.45 | 31.33 |
Total Liabilities | 874.18 | 748.61 | 587.44 | 174.61 | 119.18 | 78.28 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 490.92 | 479.96 | 414.01 | 315.18 | 252.14 | 124.22 |
Retained Earnings | -110.9 | -154.54 | -152.91 | -187.12 | -185.42 | -126.13 |
Comprehensive Income & Other | 107.65 | 89.95 | 91.84 | -25.41 | -12.34 | 3.48 |
Shareholders' Equity | 487.68 | 415.38 | 352.94 | 102.65 | 54.38 | 1.57 |
Total Liabilities & Equity | 1,362 | 1,164 | 940.38 | 277.26 | 173.56 | 79.85 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 579.86 | 467.11 | 360.16 | 12.26 | 7.1 | 1.85 |
Net Cash (Debt) | -327.95 | -325.24 | 79.84 | 72.03 | 71.97 | 14.18 |
Net Cash Growth | - | - | 10.84% | 0.09% | 407.61% | -75.74% |
Net Cash Per Share | -0.94 | -0.96 | 0.23 | 0.22 | 0.23 | 0.05 |
Filing Date Shares Outstanding | 339.78 | 338.78 | 329.55 | 323.96 | 316.71 | 308.2 |
Total Common Shares Outstanding | 339.78 | 338.78 | 334.73 | 323.73 | 316.34 | 285.07 |
Working Capital | 245.68 | 98.66 | 365.03 | 47.32 | 59.59 | 6.95 |
Book Value Per Share | 1.44 | 1.23 | 1.05 | 0.32 | 0.17 | 0.01 |
Tangible Book Value | -96.94 | -177.45 | 95.08 | 27.59 | 14.29 | -38.95 |
Tangible Book Value Per Share | -0.29 | -0.52 | 0.28 | 0.09 | 0.05 | -0.14 |
Land | - | 18.85 | 11.95 | - | 6.68 | 1.71 |
Machinery | - | 28.84 | 6.45 | - | 1.16 | 1.34 |
Construction In Progress | - | 12.44 | 9.46 | - | - | - |
Leasehold Improvements | - | 4.28 | 2.05 | - | 1.05 | 0.27 |